Skip to main content
. 2009 Jun 30;3(2):108–115. doi: 10.5009/gnl.2009.3.2.108

Fig. 3.

Fig. 3

BMI, fasting plasma glucose, fasting serum insulin, and HOMA-IR before and after antiviral treatment in patients with genotype 1 HCV infection (A, n=15) and genotype 2 HCV infection (B, n=13). Data were obtained before and at 6 months after the end of antiviral treatment. Data are mean and SD values.

*p<0.05, p<0.01.

BMI, body mass index; NS, not significant.